ArticleOphthalmology and therapy2026

One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.

Alice M Kitay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.